| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |